Features

  • Insulin moeity presented to immune system
  • Fully-biologic manufacturing
  • Insulin modified to eliminate glucose lowering
  • Insulin mutations disrupt T cell presentation
  • Fc glycosylation targets B cells for deletion
  • Animal model studies show T1D prevention